Literature DB >> 7062268

Age-related changes in hepatic microsomal drug metabolism are substrate selective.

L E Rikans, B A Notley.   

Abstract

Microsomes were isolated from livers of male Fischer 344 rats at 3 to 5, 14 to 15 and 24 to 25 months of age for the determination of monooxygenase components and drug metabolism activities. Microsomal cytochrome P-450, cytochrome b5, NADPH-cytochrome c reductase activity and phospholipid were decreased in middle-aged and old rats compared with young-adult rats, but the enzymatic reduction of microsomal cytochrome P-450 was unchanged. Drug metabolism activities both decreased and increased as a consequence of aging, depending upon the substrate used. Differences were observed between young-adult and old rats in the CO maximum of reduced microsomal cytochrome P-450, in microsomal fatty acid composition and in the amounts of microsomal polypeptides having molecular weights of 52,500 and 53,000. The substrate selectivity of the age-related alterations in hepatic microsomal drug metabolism may be due to qualitative changes in the cytochrome P-450 and phospholipid components of the monooxygenase system.

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 7062268

Source DB:  PubMed          Journal:  J Pharmacol Exp Ther        ISSN: 0022-3565            Impact factor:   4.030


  6 in total

Review 1.  Hepatic drug metabolism and aging.

Authors:  C Durnas; C M Loi; B J Cusack
Journal:  Clin Pharmacokinet       Date:  1990-11       Impact factor: 6.447

2.  Lipids and delta6-desaturase activity alterations in rat liver microsomal membranes induced by fumonisin B1.

Authors:  W C A Gelderblom; W Moritz; S Swanevelder; C M Smuts; S Abel
Journal:  Lipids       Date:  2002-09       Impact factor: 1.880

3.  Pharmacokinetics of ketamine and xylazine in young and old Sprague-Dawley rats.

Authors:  Daphnée Veilleux-Lemieux; Aude Castel; Denise Carrier; Francis Beaudry; Pascal Vachon
Journal:  J Am Assoc Lab Anim Sci       Date:  2013-09       Impact factor: 1.232

4.  Ongoing hepatocellular regeneration and resiliency toward galactosamine hepatotoxicity.

Authors:  S K Abdul-Hussain; H M Mehendale
Journal:  Arch Toxicol       Date:  1992       Impact factor: 5.153

5.  Anesthetic and pathological changes following high doses of ketamine and xylazine in Sprague Dawley rats.

Authors:  Marie-Chantal Giroux; Pierre Hélie; Patrick Burns; Pascal Vachon
Journal:  Exp Anim       Date:  2015-03-27

6.  Physiological, pharmacokinetic and liver metabolism comparisons between 3-, 6-, 12- and 18-month-old male Sprague Dawley rats under ketamine-xylazine anesthesia.

Authors:  Marie-Chantal Giroux; Raphael Santamaria; Pierre Hélie; Patrick Burns; Francis Beaudry; Pascal Vachon
Journal:  Exp Anim       Date:  2015-10-21
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.